Cargando…

Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease

Background: Alzheimer’s disease (AD) is characterized by the presence of β-amyloid plaques and neurofibrillary tangles, while Lewy body dementia (LBD) is characterized by α-synuclein (α-syn) inclusions. Some authors examine α-syn protein in the neurodegeneration process of AD and propose to consider...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monge-García, Victoria, García-Ayllón, María-Salud, Sáez-Valero, Javier, Sánchez-Payá, José, Navarrete-Rueda, Francisco, Manzanares-Robles, Jorge, Gasparini-Berenguer, Ruth, Romero-Lorenzo, Raquel, Cortés-Gómez, María Angeles, Monge-Argilés, José-Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469325/ https://www.ncbi.nlm.nih.gov/pubmed/34577877 http://dx.doi.org/10.3390/medicina57090954

Ejemplares similares

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

Comparison of Two Analytical Platforms for CSF Biomarkers of Alzheimer's Disease
por: Monge-Argilés, Jose Antonio, et al.
Publicado: (2014)

Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
por: Monge-Argilés, J. A., et al.
Publicado: (2016)

Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2018)

CSF Presenilin-1 complexes are increased in Alzheimer’s disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2013)

Presenilin 1 Modulates Acetylcholinesterase Trafficking and Maturation
por: Cortés-Gómez, María-Ángeles, et al.
Publicado: (2023)

ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels
por: Agüero-Rabes, Pablo, et al.
Publicado: (2023)

Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression
por: Cortés‐Gómez, María‐Ángeles, et al.
Publicado: (2020)

Revisiting the Role of Acetylcholinesterase in Alzheimer’s Disease: Cross-Talk with P-tau and β-Amyloid
por: García-Ayllón, María-Salud, et al.
Publicado: (2011)

Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase
por: Campanari, Maria-Letizia, et al.
Publicado: (2016)

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy
por: Lennol, Matthew P., et al.
Publicado: (2022)

Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis
por: García-Ayllón, María-Salud, et al.
Publicado: (2012)

Inhibition of γ-Secretase Leads to an Increase in Presenilin-1
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2017)

Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2016)

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
por: Abdi, Ilham Y., et al.
Publicado: (2021)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016)

Plasma ACE2 species are differentially altered in COVID‐19 patients
por: García‐Ayllón, María‐Salud, et al.
Publicado: (2021)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein
por: Barkovits, Katalin, et al.
Publicado: (2020)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
por: Agüero, Pablo, et al.
Publicado: (2020)

Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
por: Blanco-Palmero, V. A., et al.
Publicado: (2021)

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2017)

Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
por: García-Gutiérrez, Maria Salud, et al.
Publicado: (2020)

Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences
por: Navarrete, Francisco, et al.
Publicado: (2020)

Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
por: García-Gutiérrez, María Salud, et al.
Publicado: (2022)

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
por: Wurster, Isabel, et al.
Publicado: (2022)

Brain cholinergic impairment in liver failure
por: García-Ayllón, María-Salud, et al.
Publicado: (2008)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach
por: Navarro, Daniela, et al.
Publicado: (2023)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
por: Wennström, Malin, et al.
Publicado: (2013)

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2017)

Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes
por: Lennol, Matthew P., et al.
Publicado: (2023)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
por: Majbour, Nour K., et al.
Publicado: (2017)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
por: Boiten, Walter A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4fivlp62dd7923leojendekbit